FDA OKs Platelet Booster for Liver Disease Patients FDA OKs Platelet Booster for Liver Disease Patients

Avatrombopag increases platelet counts and may decrease or eliminate the need for transfusions in patients with liver disease and thrombocytopenia who are to undergo a planned medical or dental procedure.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news